Companies: 10,795·Total market cap: $144.5T

Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Inc.

COTQFOTCHealthcare

$0.00

+$0.00(+0.00%)

Market Cap$2199

P/E Ratio—

52W High$0.0001

52W Low$0.0001

Avg Volume4K

Open$0.00

Beta-9.29

Net Income Financials Revenue

Cotinga Pharmaceuticals Inc. (COTQF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

COTQF · net income · updated Jun 9, 2026

Core profitability metrics

COTQF · net income · margin · TTM · CAGR

Net income was −$2.0M for FY2019 (fiscal year ending 2019-04-30), up 47.3% year-over-year. Net profit margin was —.

FY2019 Net Income−$2.0M▲ +47.3% YoY

Trailing 12M (TTM)−$1,912.385trailing 4 quarters sum

Net Profit Margin——

YoY Change+47.3%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · COTQF net income history · COTQF profit margin

Annual net income data

COTQF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2019Loss−$2.0M▲ +47.3%—$0

FY2018Loss−$3.8M▲ +16.2%—$0

FY2017Loss−$4.5M▼ 15.5%—$0

FY2016Loss−$3.9M▼ 24.9%—$0

FY2015Loss−$3.1M▼ 15.3%—$0

Net income vs peers (Healthcare)

COTQF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Cotinga Pharmaceuticals Inc.YOU

COTQF

−$2.0M+47.3%—

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Cotinga Pharmaceuticals Inc. (COTQF) reported net income of −$2.0M for FY2019 (fiscal year ending 2019-04-30), up 47.3% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Cotinga Pharmaceuticals Inc. has not yet achieved annual profitability based on available data (7 fiscal years). The company has reported net losses across all available periods.

Cotinga Pharmaceuticals Inc.'s net profit margin was — for FY2019, based on the latest annual results.

Investors sometimes search for "Cotinga Pharmaceuticals Inc. net worth" — the company's market capitalization is a separate figure from COTQF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

COTQF net income · 4 questions

Cotinga Pharmaceuticals Inc. is not currently profitable on an annual basis. The company reported a net loss of $2.0M for FY2019.

is COTQF profitabledoes COTQF make a profitCOTQF profitabilityCOTQF profitable company

▸ Source: FMP /income-statement · GAAP · Cotinga Pharmaceuticals Inc. · Cotinga Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026